Advanced Biotechnologies Inc

TGA BioServices, an Absorption Systems'​ Company, is an FDA inspected contract research laboratory providing the Pharmaceutical, Biotechnology and Research communities a comprehensive range of laboratory services in support of research and clinical studies. We offer the client a complete package of customized testing systems utilized in preclinical through Phase IV studies, all in compliance with cGLP and cGMP requirements.

We specialize in the development and validation of immunoassay systems for the detection of target molecules, antibody responses and quantification in total compliance with QA and cGMP standards.

TGA BioServices also offers in vivo mouse studies for the optimization of vaccine immunization schedules, dosing, adjuvant screening, immunogenicity testing for the release and stability of bulk and finished clinical product, as well as complete antibody development programs. Furthermore, we offer Guinea pig dermal sensitization testing for the identification of contact allergens. All programs are supervised by an in-house Institutional Animal Care and Use Committee (IACUC), while the facility is USDA registered and AAALAC accredited.

Other services provided include FACScan cell labeling studies, tissue culture, endotoxin testing, basic R&D activities, sample storage, specimen collection kits with on-site training, data management, protocol generation (SOP), database/statistical analysis and consultation. TGA BioServices has the credentials your project is searching for.

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more.

Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.

Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community.

• Stem Cells & Cell Line Models
• Mouse Model Generation
• AAV Potency Assay
• Antibody Discovery & Screening
• Bioproduction
• Regenerative Medicine
• Pre-IND Filing Consultation

Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression.

For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.

We are a Life Science company developing innovative enzyme assay formats for a quantum improvement in performance and productivity. Our PhosphoSens® next generation Sox-based sensor platform uses proprietary technology invented in the Imperiali laboratory at MIT and is exclusively licensed to AssayQuant®. This format provides a simple and powerful solution to quantitatively measure the activity of protein kinases and phosphatases, with specificity for Tyr, Ser/Thr, or Mixed Function, using a direct, one-step homogeneous and continuous (kinetic) format. Samples can be recombinant or immunoprecipitated enzymes or crude cell or tissue lysates and assays can be read on commonly available microplate readers. This platform is ideal for elucidating drug mechanism of action, profiling and potency assessments. With multiple formats including PhosphoSens®, PhosphoSens®-Lysate and PhosphoSens®-Red and the ability to target different enzyme classes, our technologies are being applied across the discovery and drug development workflow to characterize next generation enzyme inhibitors and activators.

Contact us on our website or hello@assayquant.com to learn how our Catalog products and Custom Assay Development or Testing Services can enable your efforts.

Headquartered in the heart of one of the world's largest clusters of life science research institutes and companies, San Diego, California, BPS Bioscience Inc is a leading producer for:

bromodomains
Coronavirus
deacetylases (HDACs)
demethylases
immunotherapy related products
kinases
methyltransferases
phosphodiesterases
phosphatases
poly ADP ribose polymerases
ubiquitin enzymes

BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.

BPS also provides custom protein expression, biochemical and cell-based assays, cell line development, CRISPR, BLI and compound screening services. We are scientist founded, scientist driven. To serve our customers well, we listen to your needs and customize our services to suit your needs.

By being at the forefront of technology development, BPS focuses on providing quality life science products and services in a timely manner that will help our customers to accelerate drug discovery and development for treatment of human diseases.

To learn more about our products and services, please feel free to contact us or explore our website at www.bpsbioscience.com.